Clinical trial

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic…

NCT00199069 · Goethe University, Other · Completed

Key facts

NCT number NCT00199069
Title German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (05/93)
Official title Multicenter Trial for Treatment of Acute Lymphoblastic Leukemia in Adults (05/93)
Lead sponsor Goethe University, Other
Collaborators Deutsche Krebshilfe e.V., Bonn (Germany)
Status Completed
Phase Phase 4
Study type Interventional
Conditions Adult Acute Lymphocytic Leukemia
Intervention type Drug, Procedure
Interventions Asparaginase, Vincristine, Daunorubicin, Adriamycin, Cyclophosphamide, Ifosfamide, Cytarabine, Mitoxantrone, Methotrexate, 6-Mercaptopurine and 6 more
Enrollment 720
Start date Apr 1, 1993
Primary completion Jan 1, 1999
Completion May 1, 2001
First posted Sep 20, 2005
Last update posted Mar 17, 2023
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies